Sat Prabhava offers next-generation treatments like ATMPs and personalised cancer vaccines. These advanced therapies activate your immune system at a cellular level, helping you fight cancer with precision and long-term protection.
Advanced Autologous and Immune-Driven Therapies for Long-Term Cancer Control
At Sat Prabhava, we offer a comprehensive suite of Advanced Therapy Medicinal Products (ATMPs) that include cellular immunotherapies, cancer vaccines, oncolytic viruses, and gene-silencing technologies—all designed to target cancer at its roots and support long-term immune surveillance.
These therapies are based on the principle of personalised immuno-genomics—using your unique tumour mutations, antigen profiles, and immune signatures to guide treatment. Our ATMP platform includes:
- Autologous cellular therapies, Personalised peptide or neoantigen vaccines, Oncolytic viruses, Gene silencing therapies etc
- These treatments are especially impactful in advanced, recurrent, or treatment-resistant cancers and are integrated with chemotherapy, targeted therapies, or supportive modalities to enhance safety and efficacy.
“At Sat Prabhava, tomorrow’s medicine starts with you—your cells, your tumour’s blueprint, your immune response—all working together through personalised, advanced therapeutics designed for lasting cancer control.“